BioProcess International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, announces an agreement with Pall Life Sciences to become a program sponsor of the 2014 BioProcess International Awards – the most honorable accolades for the global biopharmaceutical industry. The awards allow the industry to nominate individual achievements, collaborations, successful business strategies, social corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to…

  Billerica, MA—August 22, 2014—EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announces that EMD Millipore and Samsung BioLogics have signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business. The alliance is intended to encompass a long-term supply agreement in which EMD Millipore will provide raw materials for biopharmaceutical manufacturing. Dr. Udit Batra, President and CEO of EMD Millipore, and Benoit Gourdier, head of EMD Millipore’s Process Solutions Asia, were present at the signing…